Cargando…
Now we are 30: 10 more years of MASCC
This paper chronicles the third decade of MASCC from 2010. There was a generational change in this decade, building on the solid foundation of the founders. It included the first female President, and a new Executive Director with a background in strategy and business development and operations as a...
Autores principales: | Olver, Ian N., Chin, Melissa, Lalla, Rajesh V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825387/ https://www.ncbi.nlm.nih.gov/pubmed/33484357 http://dx.doi.org/10.1007/s00520-021-05998-0 |
Ejemplares similares
-
MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer
por: Madariaga, Ainhoa, et al.
Publicado: (2022) -
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
por: Lalla, Rajesh V., et al.
Publicado: (2014) -
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
por: Elad, Sharon, et al.
Publicado: (2020) -
Venoms as an adjunctive therapy for Parkinson’s disease: where are we now and where are we going?
por: Gazerani, Parisa
Publicado: (2020) -
Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper
por: Cooksley, Tim, et al.
Publicado: (2020)